Ilya Yuffa, head of international for US weight-loss drugmaker Eli Lilly, wants Australia to shrink the approval time for new medicines. Dominic Lorrimer Ilya Yuffa, who heads Eli Lilly’s ...

announcing its first pharma partnerships with Eli Lilly and Novartis, worth almost $3 billion. The company – led by Google DeepMind Founder Demis Hassabis and formed just over two years ago ...

On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the plate with a major plan to grow its U.S. footprint. Novartis will ...

Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular disease risk factor for nearly 1.5 years, bolstering the company’s argument that the siRNA candidate has an edge over ...

UK cost-effectiveness agency NICE has said that Eli Lilly ... In the same period, Lilly reported sales of $253 million for Emgality, and Teva made $98 million from Ajovy. Novartis is hoping ...